Design, synthesis, biological evaluation and in silico studies of EGFR inhibitors based on 4-oxo-chromane scaffold targeting resistance in non-small cell lung cancer (NSCLC)
Kshipra S. Karnik, Aniket P. Sarkate, Shailee V. Tiwari, Rajaram Azad, Pravin S. Wakte
Topics & Concepts
ChemistryIn silicoT790MIC50CytotoxicityEGFR inhibitorsIn vitroKinaseEnzymeBiochemistryDPPHCombinatorial chemistryPharmacologyCancer researchEpidermal growth factor receptorAntioxidantBiologyReceptorGeneGefitinibSynthesis and biological activityCancer therapeutics and mechanismsLung Cancer Treatments and Mutations